OBSTRUCTIVE SLEEP APNOEA SYNDROME AND HYPERTENSION - DIAGNOSIS AND NON-CPAP THERAPIES
Authors: Simona Macesanu
Introduction: Obstructive sleep apnoea syndrome (OSAS) is common, but under-diagnosed, with an estimated prevalence of up to 20%. Observational studies have found OSAS to be associated with increased cardiovascular morbidity, mortality and healthcare costs. Identifying patients with clinically symptoms of OSAS may be useful for targeting treatment to those of greatest risk.
However, isn’t interest for sleep disease diagnosis in the ambulatory, although investigation of OSAS is easily performed.
Methods: In ambulatory at County Hospital of Emergency Timisoara,we investigated patients with OSAS and hypertension with comorbidities, was used respiratory portable polygraph, Epworth Questionaire, clinical examination and was selected the treatements non-invasive therapy, non-CPAP. Observational clinical study, enroled twelve patients, 33-68years, of both sexes, with IAH min 14,1/h -max 61,8/h, mean 39,78/h, which were associated severe snoring, nocturnal desaturation (mean 30,7/h), lowest SpO2 (mean 73,41%), overweight or obesity (BMI 36,47), hipertension, ventilatory disfunction, chronic rhinitis.
Results: Patients wich are not willing to treat with CPAP have applied alternative non-CPAP therapies, diet, with significant weight loss, treatment Otolaryngology - nasal decongestants, orally or nasal inhaled ICS, respiratory gymnastics; Surgical therapies are not available.
Conclusion: Our findings indicate that lose weight it is the most easy way to treat OSA mild and moderate. Patients with severe IAH who are not willing to treat with CPAP for reasons preconceived, have the cardiovascular risk unchanged.